Apparatus for applying pulsed charge to living matter

Apparatus for inducing electrically charged alignment changes in biological tissue includes a generally flat translucent cavity containing a volume of gas that includes water vapor, carbon dioxide and other similarly common molecules that is charged along one surface by a sequence of pulses of electrical charge each of a potential sufficient to excite the common molecules to a higher state. The opposite side of the cavity is then conformed for intimate contact with the skin of a person, thus communicating the right hand spin electromagnetic pulses associated with each excitation level change into the tissue. A pulsed coil is then provided in an alignment generally parallel to the plane of the cavity to polarize the clockwise electromagnetic emissions associated with the changes in the excitation states.

BACKGROUND OF THE INVENTION

1. The Technical Field

The present invention relates to pulsed charge devices, and more particularly to charged surfaces coupled to anatomical parts polarized to a right hand clockwise spin by a pulsed electromagnetic field to induce electron state changes in the biological matter.

2. The Prior Art

In my prior U.S. Pat. No. 6,328,760 issued on Dec. 11, 2001 I have described a plasma device conformed to ionize certain prevalent biological elements and molecules with the emission spectra of this ionization process then coupling efficiently with the dominant element and molecular structures in living matter. In consequence, repair and reconstruction of living cells is both accelerated and enhanced by the illumination with these selected spectra. Since that time I have discovered that a filly developed ionization process need not be utilized and an electrical potential between the living matter and the charge sufficient to change some of the electron states of the molecular combinations of living tissue may produce the necessary molecular lattice rearrangement to promote growth or healing.

Earlier I and others have observed that virtually all living functions entail electrical potential balances and the cell itself closely mimics a ‘wet circuit’. Sporadic disruptions of these potential balances, either because of the introduction of some contaminant or as result of some unwanted change in the charge architecture, seem to be the causative events that lead to disease and it is the rearrangement of this charge architecture anomalies that appear to be at the heart of the process that I earlier described in the '760 us patent. Of course, excepting those abnormalities that reach into the genome itself most of these electro-potential effects seem to be at the larger or macro level, such as those affecting the Na+/K+ pump, and the excitation of just some of the more basic molecules appears to be sufficient to assist in rearranging the other charge architectures back to their normal states.

The foregoing effect appears to have some confirmation in scientific literature. For example, Horwitz, L R, Burke, T J, Carnegie, D, 1999. Augmentation of Wound Healing Using Monochromatic Infrared Energy; Exploration of a New Technology for Wound Management.Advances in Wound Care12:35-40 describes the use of 890 nanometer monochromatic light effectively treating recalcitrant dermal lesions and ulcers that sometimes resisted conventional care for more than 39 years. Similarly, living tissue molecular array response to weak electric and magnetic fields has long been recognized. See, e.g., Adey, W R, Bawin, S M Brain Interactions with Weak Electric and Magnetic Fields.Neurosciences Research Program Bulletin15(1):1-129. These and other publications clearly establish an interactive relationship between living tissue and weak electromagnetic fields.

Notably, however, this same effect is also associated with emission of light in unique and distinct spectral patterns with a symmetrical result then obtained by absorption of the light energy in similar molecular structures illuminated thereby. In the bulk tissue structure this interchange is polarity dependent obtainable in an electromagnetic right hand spin polarizing field which may be overlayed over the emitting source. Accordingly, a mechanism for conveniently producing such right hand spin polarized emission fields that induce response in living tissue including electron state changes is extensively desired and it one such mechanism that is disclosed herein.

SUMMARY OF THE INVENTION

Accordingly, it is the general purpose and object of the present invention to provide a pulsed charge field contained in an electromagnetic field conformed for raising the excitation states of molecular bonding in biological molecules.

Other objects of the invention are to provide a pulsed charge field including frequency spectra in each pulse within the frequency domain of a wet circuit.

Yet further objects of the invention are to provide a pulsed charge circuit completed through the charge architecture of living matter.

Further objects of the invention are to provide a conveniently implemented electrical charge field in circuit with the wet circuit charge architecture of living matter.

Yet additional objects of the invention are to provide a right hand spin polarizing electromagnetic field superposed onto a charge field conformed to raise the excitation state of biological matter.

Briefly, these and other objects are accomplished within the present invention by providing a direct current powered oscillator circuit transformer coupled to a plurality of voltage doubler stages connected to the positive charge terminal that is shaped in the form of a flat plate. The plate, in turn, is enclosed on the exterior surface of a generally flat gas filled chamber that can be pressed to the selected limb or body area of a person with the local charge differential across the chamber then providing localized electrical potentials which effect an energy state change in the gas along with the associated radiation. By selecting a molecular structure of the gas similar to the molecular structures in the adjacent tissue a part of the emitted radiation is then absorbed in the adjacent molecular arrays of the body, raising the excitation levels in the tissue which propagate until a local equilibrium is reached. This equilibrium includes the ambient setting through which the ground return part of the circuit is completed, with the lack of observable radiation then providing an indication that the circuit impedance may be too high, i.e., that the contact skin area may be too dry. In this manner the polar molecules that are associated with all living tissue are included in the circuit lattice responding both to the electrical potential and to the gas emitted radiation.

The radiated emissions thus produced can then be further controlled by a superimposed electromagnetic field produced on the interior of a coil surrounding the flat negatively charged plate and the chamber on which it is fixed. A further pulse circuit may then be connected across the coil, thus exciting the electromagnetic field to its selected pulse frequency. As result the emissions in the chamber are uniformly right hand spin polarized along their vectors that coincide with the field vector within the coil, thus insuring a relatively uniform absorption within the generally polar architecture of the molecular lattice that forms the irradiated tissue.

Those skilled in the art will appreciate that virtually all organic molecules are associated with a distributed electrical charge. Very frequently it is this charge distribution that determines the lobes and foldings of the larger molecules like proteins or peptides and it is the occasional distortions in this charge determined geometry that is often the suspected causative agent associated with disease. Simply, the lobe architecture of a large molecule may be altered by external effects which then alters the molecular interactions with, e.g., receptors, until rearranged to equilibrium state. Of course, the disease consequence associated with distortions in our largest molecules, the chromosomes, are well appreciated at this time and fundamental reasoning dictates that the adjacent smaller molecules will invariably have some effect across the whole range of molecular sizes. It is this effect that is conveniently allowed to resolve itself by the inventive structure disclosed herein.

DESCRIPTION OF THE PREFERRED EMBODIMENT

By reference toFIG. 1my prior U.S. Pat. No. 6,328,760 teaches a pulsed plasma radiation tube RT excited by a pulse circuit PC to ionization potential of the gases contained therein selected to emit radiation RA in biologically significant spectra onto the treated body area BA of a user. To achieve this radiation the gas within the plasma tube RT included molecules like water vapor or H2O, carbon dioxide CO2, molecular nitrogenN2 and perhaps carbonic acid H2CO3 all driven to ionization by the pulse circuit PC. The resulting radiated spectra were then useful in exciting illuminated tissue containing corresponding molecules, or loosely bound components of larger molecules like peptides or proteins, and the higher energy states of these excited elements and molecules would induce, in the manner of a cascade, further state changes propagated through the wet circuit of a cell. In this propagation process any molecular distortions or electrical charge misalignments would be freed up to return to their preferred state. These molecular rearrangement by this negatively ionized gas spectral illumination process have resulted in substantial molecular responses, both useful in promoting healing and in the maintenance of proper homeostasis.

While suitable for the purposes intended and widely useful in the care of various diseases I have since found that the higher potentials of full ionization are not necessary and, in stead, only a sufficient charge difference to obtain an electron state response need be applied. Although not fully understood, it appears that the lattice of polar molecules that are included in all living tissue provides its own charge distributions at the body surface and this distribution may be used to advantage in producing sufficient electric potential to effect an electron state change. Of course, this is associated with a release of radiation which then raises the state of other electrons and this state change then cascades down into the treated tissue through its molecular lattice until all the available state changes can be effected, and so on. In this manner large body areas can be influenced with relatively low electric potentials.

This lower level of charge differential can be conveniently effected by modifying the pulse circuit of my earlier U.S. Pat. No. 6,328,760 and the teachings thereof are incorporated herein. By reference toFIGS. 2 through 5and by further reference to the teachings of my prior '760 patent, like numbered parts functioning in the like manner to that previously described, the inventive system generally designated by the numeral110includes a generally rectangular gas impervious chamber120defined by a flat transparent front panel121peripherally bonded to the edges of a mating concave rear panel122to form a closed cavity123therebetween. A conductor125is then extended along the exterior of the rear panel122deploying a flat sheet electrode126over chamber120under a sealing membrane124adhered to the edges of rear panel122.

Similar to the teachings of my prior '760 patent chamber120may be filled with a gaseous mixture of common molecules like water vapor, carbon dioxide, carbonic acid and the like, each readily brought to a higher excitation state by electrical charge of electrode126. To develop this charge potential the other end of conductor125, in turn, connects to a pulsed power source generally designated140comprisng a pulse stage60of similar construction to that shown by the same numeral in my prior '760 patent, gated by a voltage controlled oscillator61set in its oscillation frequency by a potentiometer62in a voltage divider circuit between the positive signal E− and ground. The output of oscillator61drives to saturation at both limits of an operational amplifier63which is then amplified by a power amplifier65that is tied to the primary of a transformer45the secondary thereof driving a voltage multiplier150comprising a lattice of diodes51-1through51-m interconnected by capacitors52with the last doubler stage at diode51-m then connecting to the conductor125.

In accordance with the present invention the pulse potential EF of conductor125is well below the ionization level of the gases in cavity123but is sufficient to exceed the bonding potential of the typical outer electrons of organic molecules, e.g., voltages less than 50 volts. Thus only singular electromagnetic wavelengths A associated with electron state change are emitted, particularly those containing the spectra of the common molecular states.

It will be appreciated by those skilled in the art that the foregoing pulse circuit is configured substantially like the pulse circuit in the '760 patent. By reducing the number of multiplication stages, however, the effective potential is substantially below that resulting in ionizing disassociation and the effect is primarily one of electric potential or charge. By particular reference toFIG. 3this charge effect couples with the polar molecules like water WA-1through WA-r, other polar organic molecules like peptides PE-1through PE-s, proteins PR-1through PR-t and so on. In the presence of an electric charge field these will arrange in lattices or arrays AR where the polar difference across this molecular array in the tissue and the molecular lattice of the gas within cavity123is less than the potential EF at the electrode126. The excess electrode potential is then useful to effect an electron state change along with the associated shedding of light that may then cascade to excite corresponding molecules WA-1through WA-r in the tissue structure.

Those skilled in the art will appreciate that the foregoing inventive system includes inherent discharge preferences that seek out the shortest discharge paths. To confine these discharge effects to a path across chamber120, and preferably not across the conductor125to ground, an applicator structure is illustrated inFIG. 6under the generally numbered designation210in which like numbered parts function in like manner to those previously described. More precisely, applicator210is characterized by a generally cylindrical handle211of a substantial radial and longitudinal dimension and a dielectric material selected to insulate the pulsed power source140including all the operative components thereof. An electrical lead212then extends into handle211to provide the power signal E+ to circuit140which then generates the sequence of pulses on the output conductor125and the rectangular sheet electrode126. Chamber120is formed on the interior of an offset rectangular piece221extending in cantilever from handle211with the electrode126mounted on the rear surface222thereof and thereafter sealed by an exterior membrane224in this deployment. The front surface223of piece221can then be manipulated into any desired contact alignment with the skin SK of the user. By selecting the material dielectric coefficients and geometric spacing dimensions this structure insures that the minimal discharge path is across chamber120, thus insuring that the user's hand UH does not by-pass the desired effect. In this manner the primary result is the one previously described, a result that assists in realigning the various molecular lobe structures of the biological molecules affected.

I have further found that the foregoing effect can be greatly enhanced by concurrently polarizing the common vectors of each of the emitted light energy in cascade into an alignment along with the charge field vector. To provide this right hand spin polarization an electromagnetic field is developed in accordance with the illustrations inFIGS. 7-9, wherein like numbered parts function in like manner to that previously described. More precisely, a coil161is wound around the interior periphery of chamber120in a plane generally parallel to the plane of the sheet electrode126in either one of the two applicator forms10and210, with the ends162and163of the coil then connected across yet another pulse circuit160exemplified by the implementation shown inFIG. 9, wherein an oscillator circuit is formed by cross coupling the collector to base connections between two transistors181and182with the base bias of transistor182controlled by a potentiometer183which, in combination with the other resistors R1, R2through Rs and capacitors C1and C2, set the desired oscillation frequency. The collector of transistor182then drives the base of a transistor184in a switching circuit formed by gating a transistor185in and out of conduction in a circuit connection between the coil end163and ground, with the other end162of coil winding161connected to the power source E+. In this manner a generally square wave pulse sequence is developed across the coil, producing an electromagnetic field vector EMF aligned generally orthogonally to the plane of the sheet electrode126and cavity120and coinciding with the emitted radiation field vector EF.

By particular reference toFIG. 8, the electromagnetic field vector EMF imposes a corresponding uniformly aligned right hand spin to the spectra A emitted by the constituent elements like O, C, H and N both within chamber120and also in the adjacent tissue, shown symbolically as the electromagnetic wavelengths right hand spin vectors AS1through ASm. By well known principles of physics this coherent realignment of the spin vectors is obtainable without any energy exchange, thus promoting a generally uniform, polarized cascade through the tissue array AR in the course of their emission and absorption that has little or no collateral energy exchange associated therewith. I have found that electromagnetic field levels as low as 0.7 Gauss are sufficient for effective penetration of the field EMF through the adjacent tissue. Thus the major risks associated with high energy irradiation are minimized by limiting both the magnetic flux and the relative electric potential of the electrode120to 50 volts. In this manner irradiation of sensitive biological elements, like those in the human eye, is rendered safe allowing for the charge realignments and correction of all-trans retinal molecules, peptides, proteins and chromosomes.

The usefulness of this irradiation process has had received extensive verification in the course of Phase Two clinical trials recently conducted to verify the therapeutic efficacy of the inventive device in treating Age-Related Macular Degeneration [AMD], Diabetic Retinopathy and Retinitis Pigmentosa, all retinal diseases with few known treatment modalities. Periodic irradiation of the retina of AMD patients, for example, directly through the eye lens, in 20 minute intervals, has shown measurable improvement in visual acuity as measured by the Vector Vision LogMar instrumentation with one improvement as high as 57% and an improvement average of 16%. Even higher treatment averages were obtainable with a patient population that was limited to early-stage AMD, with visual acuity improvement averages as high as 33%.

By reference toFIGS. 10aand10bthis irradiation treatment of the retina can be rendered convenient by a holding structure generally designated by the numeral310, comprising a generally circular strap311provided with overlapping ends312and313engageable to each other by opposing hook and pile segments, like those sold under the mark “VELCRO”, respectively shown as end segments312hand313p, to form a hoop of various peripheral dimensions. A holding bracket315may then be selectively clipped to the strap311by interlaced engagement thereof between offset tines316extending therefrom to deploy the applicator structure210over and adjacent to the anatomical area that is to be irradiated. As exemplified inFIGS. 8 and 10astrap311is positioned about the circumference of a head of a patient with the holding bracket315then clipped to the strap311over the forehead to extend over the patient eyes EY with the irradiation then focused by the eye lens EL onto the retina ER. With this assistance the applicator structure210can be conveniently held right over the eyes for the necessary durations determined by any treatment regimen. Alternatively, as illustrated inFIG. 10bthe bracket is clipped to the strap311in alignment over the anterior surfaces of the skull SA containing the visual cortex.

It is believed that by way of this polarized irradiation small biological structures like the walls of the 0.8 micron diameter capillary bed of the retinal macula RM are charged to an equal polarity, thus promoting wall separation for an increased flow. In consequence, circulation for nourishment and removal of by-products is re-established, resolving the principal source for the pathology of macular degeneration. I have further observed that this process is rendered particularly effective in the spectral emission and reabsorption of hydrogen in the 450 nanometer emission band, suggesting the involvement of the hydrogen atom via the All-trans-Retinal in the cones of the macula RM. This is consistent with the generally observed deterioration with age in the retinal perception of the blue color, now regenerated by this inventive process, thereby restoring the full visual range from the ultraviolet to the infrared. Of course, similar benefits should follow in other biological structures.

By this simple expedient the device can be variously deployed over the body of the patient, resolving most degenerative molecular malformations in the targeted tissue. Of course, other shapes of the applicator structure210may be devised with particular attention to the body shape that is intended for exposure, such as cavities convolved into toroidal shapes to surround a digit or limb or similar adaptations. In each instance, however, the geometric constraint that needs to be met is one that assures that the minimal discharge path is across the cavity.

By reference toFIG. 11the spectral distribution of the emissions from chamber120has been confirmed by actual measurement including the several spectral peaks SP1-SPq associated with biological matter and also the very pronounced hydrogen emission spectrum peak HSP at 450 nanometer emission band referenced above. Thus the theoretically inferred results are directly confirmed by measurement which has been thereafter further confirmed by clinical trials. Thus a conveniently deployed, relatively safe treatment mechanism is devised which is broadly useful in realigning the molecular architecture, and therefore the local charges, of living matter

Obviously, many modifications and variations can be effected without departing from the spirit of the invention instantly disclosed. It is therefore intended that the scope of the invention be determined solely by the claims appended hereto.